These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21873226)

  • 1. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats.
    Cummings BP; Bettaieb A; Graham JL; Stanhope KL; Dill R; Morton GJ; Haj FG; Havel PJ
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14670-5. PubMed ID: 21873226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats.
    Cummings BP; Stanhope KL; Graham JL; Baskin DG; Griffen SC; Nilsson C; Sams A; Knudsen LB; Raun K; Havel PJ
    Diabetes; 2010 Oct; 59(10):2653-61. PubMed ID: 20622169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid.
    Cummings BP; Stanhope KL; Graham JL; Evans JL; Baskin DG; Griffen SC; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1343-50. PubMed ID: 20147607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
    Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats.
    Hidaka S; Yoshimatsu H; Kondou S; Tsuruta Y; Oka K; Noguchi H; Okamoto K; Sakino H; Teshima Y; Okeda T; Sakata T
    FASEB J; 2002 Apr; 16(6):509-18. PubMed ID: 11919153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats.
    Cummings BP; Bettaieb A; Graham JL; Kim J; Ma F; Shibata N; Stanhope KL; Giulivi C; Hansen F; Jelsing J; Vrang N; Kowala M; Chouinard ML; Haj FG; Havel PJ
    Dis Model Mech; 2013 Mar; 6(2):443-56. PubMed ID: 23264565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats.
    Zhou J; Zhang J; Luo X; Li M; Yue Y; Laudon M; Jia Z; Zhang R
    Eur J Pharmacol; 2017 Oct; 812():225-233. PubMed ID: 28687198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism.
    Birkenfeld AL; Lee HY; Majumdar S; Jurczak MJ; Camporez JP; Jornayvaz FR; Frederick DW; Guigni B; Kahn M; Zhang D; Weismann D; Arafat AM; Pfeiffer AF; Lieske S; Oyadomari S; Ron D; Samuel VT; Shulman GI
    J Biol Chem; 2011 Oct; 286(42):36163-70. PubMed ID: 21832042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment does not augment the anti-diabetic effects of liraglutide in UCD-T2DM rats.
    Swarbrick MM; Cox CL; Graham JL; Knudsen LB; Stanhope K; Raun K; Havel PJ
    Endocrinol Diabetes Metab; 2023 Jan; 6(1):e392. PubMed ID: 36480511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
    Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
    Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.
    German JP; Wisse BE; Thaler JP; Oh-I S; Sarruf DA; Ogimoto K; Kaiyala KJ; Fischer JD; Matsen ME; Taborsky GJ; Schwartz MW; Morton GJ
    Diabetes; 2010 Jul; 59(7):1626-34. PubMed ID: 20424233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms.
    Li X; Wu X; Camacho R; Schwartz GJ; LeRoith D
    PLoS One; 2011 Feb; 6(2):e17058. PubMed ID: 21379576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.
    Cummings BP; Strader AD; Stanhope KL; Graham JL; Lee J; Raybould HE; Baskin DG; Havel PJ
    Gastroenterology; 2010 Jun; 138(7):2437-46, 2446.e1. PubMed ID: 20226188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.
    Zouhar P; Rakipovski G; Bokhari MH; Busby O; Paulsson JF; Conde-Frieboes KW; Fels JJ; Raun K; Andersen B; Cannon B; Nedergaard J
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E72-E86. PubMed ID: 31743040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.
    Mannucci E; Ognibene A; Cremasco F; Bardini G; Mencucci A; Pierazzuoli E; Ciani S; Fanelli A; Messeri G; Rotella CM
    Diabet Med; 2000 Oct; 17(10):713-9. PubMed ID: 11110504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat.
    Chen XQ; Dong J; Niu CY; Fan JM; Du JZ
    Endocrinology; 2007 Jul; 148(7):3271-8. PubMed ID: 17379644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats.
    Cummings BP; Bettaieb A; Graham JL; Stanhope KL; Kowala M; Haj FG; Chouinard ML; Havel PJ
    Endocrinology; 2012 Aug; 153(8):3620-32. PubMed ID: 22719048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.